Nirsevimab EMA regulatory submission accepted under accelera

Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants

Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants

miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Japan , Cambridge , Cambridgeshire , United Kingdom , Astrazeneca Synagis , Drug Administration , European Medicines Agency Priority , Nasdaq , Company On Twitter Astrazeneca , Global Head Of Research , Astrazeneca , European Medicines Agency , National Medical Products Administration , Japan Agency For Medical Research , Committee For Medicinal Products Human Use , China Center , Marketing Authorisation Application , Medicinal Products , Human Use , Executive Vice President , Global Head , Breakthrough Therapy Designation , Drug Evaluation , Drug Selection , Promote New Drug Development , Japan Agency , Medical Research , Collaboration Revenue , Swedish Orphan Biovitrum , Biologics License Application , Rare Diseases ,